2016
DOI: 10.1016/j.jpba.2015.05.023
|View full text |Cite
|
Sign up to set email alerts
|

Development of a validated LC–APCI-MS/MS method to study the plasma and tumor distribution of CHO-PTX intravenous lipid emulsion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2016
2016
2017
2017

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 38 publications
0
3
0
Order By: Relevance
“…Previous efforts on improving its stability have been focused on developing the paclitaxel-cholesterol prodrug with increased lipophilicity (20,21). What we found is that the lipid emulsion loaded with the paclitaxel-cholesterol prodrug Improved safety and efficacy of a lipid emulsion loaded with a paclitaxel-cholesterol complex for the treatment of breast tumors exhibited long-term stability and high intratumoral accumulation (20), but the in vivo antitumor effect was greatly reduced in comparision to Taxol (unpublished data), which may attribute to the low concentration of PTX released from the paclitaxel-cholesterol prodrug by in vivo enzymatic cleavage. Alternatively, a paclitaxel-cholesterol complex connected by intermolecular hydrogen bonds was prepared and a novel lipid emulsion (PTX-CH Emul), which was composed of a paclitaxel-cholesterol complex surrounded by a phospholipid monolayer, was engineered in our previous study (22).…”
Section: Introductionmentioning
confidence: 99%
“…Previous efforts on improving its stability have been focused on developing the paclitaxel-cholesterol prodrug with increased lipophilicity (20,21). What we found is that the lipid emulsion loaded with the paclitaxel-cholesterol prodrug Improved safety and efficacy of a lipid emulsion loaded with a paclitaxel-cholesterol complex for the treatment of breast tumors exhibited long-term stability and high intratumoral accumulation (20), but the in vivo antitumor effect was greatly reduced in comparision to Taxol (unpublished data), which may attribute to the low concentration of PTX released from the paclitaxel-cholesterol prodrug by in vivo enzymatic cleavage. Alternatively, a paclitaxel-cholesterol complex connected by intermolecular hydrogen bonds was prepared and a novel lipid emulsion (PTX-CH Emul), which was composed of a paclitaxel-cholesterol complex surrounded by a phospholipid monolayer, was engineered in our previous study (22).…”
Section: Introductionmentioning
confidence: 99%
“…, ; Xia et al . , ). Despite the advantages offered by our current method with respect to sample handling and pre‐analytical processing, further improvements are required with respect to the limit of detection (sensitivity) and analysis time (retention).…”
Section: Resultsmentioning
confidence: 97%
“…, ; Xia et al . , ). In particular, liquid chromatography coupled with tandem mass spectrometry (LC–MS/MS) is a well‐established analytical tool owing to its inherent specificity and sensitivity.…”
Section: Introductionmentioning
confidence: 97%